본문으로 건너뛰기
← 뒤로

Expanding the Inhibitory Potential of the Benzoxaborinine Scaffold against Carbonic Anhydrases: Synthesis, Structural Characterization, and Antitumor Activity.

2/5 보강
Journal of medicinal chemistry 📖 저널 OA 13.8% 2023: 1/1 OA 2024: 1/8 OA 2025: 14/81 OA 2026: 14/134 OA 2023~2026 2026 Vol.69(6) p. 7414-7426 Enzyme function and inhibition
TL;DR A series of 2H-benzoxaborinines synthesized via an "aromatic metamorphosis" strategy based on the nickel-catalyzed insertion of boron into benzofuran scaffolds were evaluated as novel carbonic anhydrase (CA) inhibitors and demonstrated superior antiproliferative activity against human triple-negative breast cancer and glioblastoma cancer cell lines.
Retraction 확인
출처
PubMed DOI OpenAlex Semantic 마지막 보강 2026-05-02
OpenAlex 토픽 · Enzyme function and inhibition Ferrocene Chemistry and Applications Magnetism in coordination complexes

Renzi G, Masoni L, Carta F, Ferraroni M, Massardi ML, Tassone N

📝 환자 설명용 한 줄

A series of 2H-benzoxaborinines synthesized via an "aromatic metamorphosis" strategy based on the nickel-catalyzed insertion of boron into benzofuran scaffolds were evaluated as novel carbonic anhydra

이 논문을 인용하기

↓ .bib ↓ .ris
APA Gioele Renzi, L. Masoni, et al. (2026). Expanding the Inhibitory Potential of the Benzoxaborinine Scaffold against Carbonic Anhydrases: Synthesis, Structural Characterization, and Antitumor Activity.. Journal of medicinal chemistry, 69(6), 7414-7426. https://doi.org/10.1021/acs.jmedchem.6c00163
MLA Gioele Renzi, et al.. "Expanding the Inhibitory Potential of the Benzoxaborinine Scaffold against Carbonic Anhydrases: Synthesis, Structural Characterization, and Antitumor Activity.." Journal of medicinal chemistry, vol. 69, no. 6, 2026, pp. 7414-7426.
PMID 41814644 ↗

Abstract

In this work, a series of 2-benzoxaborinines was synthesized via an "aromatic metamorphosis" strategy based on the nickel-catalyzed insertion of boron into benzofuran scaffolds and were evaluated as novel carbonic anhydrase (CA) inhibitors. All compounds were evaluated against seven human CA isoforms (I, II, IV, VA, VII, IX, and XII), with several derivatives displaying low-nanomolar inhibitory activity. X-ray crystallographic analysis of the complexes of 2-benzoxaborinine with hCA I and hCA II revealed significant differences compared with the 1-benzoxaborinine analogue, which can be attributed to the increased structural rigidity of the scaffold. Finally, the selected compounds (, , , and ) were further evaluated for their antiproliferative activity against human triple-negative breast cancer (MDA-MB-231) and glioblastoma (U87MG) cancer cell lines, with derivative demonstrating superior antiproliferative activity compared with the antitumor CA inhibitor SLC-0111.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반